Journal article
Sleep Improvement for Metabolic Health: A Feasibility Trial of a Digital Sleep Treatment in People With Insomnia and Non‐Diabetic Hyperglycaemia
- Abstract:
- Insomnia may play a causal role in type 2 diabetes (T2D). Addressing insomnia through cognitive behavioural therapy (CBTi) in people with non‐diabetic hyperglycaemia could potentially reduce the risk of progression to T2D. To inform a future randomised trial, we performed a feasibility study of digital CBT (dCBTi) in individuals at increased risk of T2D. Participants were identified from 10 primary care practices in the UK and given access to dCBTi. Outcomes were evaluated at baseline (Week‐0) and post‐treatment (Week‐11). Primary feasibility outcomes were ability to recruit and treatment engagement. We also quantified within‐group mean change (95% CI) in insomnia severity (Insomnia Severity Index), health‐related quality of life (EQ‐5D‐3L), depression (Center for Epidemiologic Studies Depression Scale), chronotype (reduced Morningness‐Eveningness Questionnaire), sleep (7‐day actigraphy and diary), continuous glucose monitoring (7‐days) and fasting blood metabolites (insulin, lipids, glucose and C‐reactive protein). The recruitment target was 20. Of 242 people completing screening, 36 were eligible and 24 were enrolled (age 65.5 ± 12.4 years, 70.8% female). Twenty‐three (96%) completed post‐intervention assessments. Treatment engagement was excellent (83.3% completed ≥ 4 sessions). The intervention was associated with a large reduction in insomnia severity [−4.7 (95% CI: −6.2 to −3.2), d = −1.4] and medium reduction in depressive symptoms [−2.7 (95% CI: −5.1 to −0.2), d = −0.5]. Sleep diary parameters tended to show greater improvement following intervention relative to actigraphy. There was evidence of a reduction in serum lactate, glycerol and triglycerides but no clear change in glucose or insulin. Results suggest a full trial is likely feasible and that people with NDH find the intervention acceptable and beneficial. Trial Registration: This trial was prospectively registered on the UKs clinical study registry, the ISRCTN (ISRCTN19682964, https://doi.org/10.1186/ISRCTN19682964)
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 587.7KB, Terms of use)
-
- Publisher copy:
- 10.1111/jsr.70306
Authors
+ NIHR Oxford Biomedical Research Centre
More from this funder
- Funder identifier:
- 10.13039/501100013373
- Grant:
- BRC‐1215‐20008
- Publisher:
- Wiley
- Journal:
- Journal of Sleep Research More from this journal
- Pages:
- e70306
- Article number:
- e70306
- Publication date:
- 2026-02-15
- Acceptance date:
- 2026-01-25
- DOI:
- EISSN:
-
1365-2869
- ISSN:
-
0962-1105
- Language:
-
English
- Keywords:
- Source identifiers:
-
3762448
- Deposit date:
-
2026-02-16
- ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.
Terms of use
- Copyright date:
- 2026
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record